KYMR – Kymera Therapeutics, Inc.
KYMR
$47.71Name : Kymera Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $3,106,855,936.00
EPSttm : -3.11
Kymera Therapeutics, Inc.
$47.71
Float Short %
13.14
Margin Of Safety %
Put/Call OI Ratio
0.68
EPS Next Q Diff
-0.11
EPS Last/This Y
-0.62
EPS This/Next Y
-0.4
Price
47.66
Target Price
62.32
Analyst Recom
1
Performance Q
46.47
Relative Volume
1.55
Beta
2.07
Ticker: KYMR
21 items
«
‹
of 1
›
»
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
---|---|---|---|---|---|
2025-05-07 | KYMR | 29.06 | 0.40 | 0.33 | 3345 |
2025-05-08 | KYMR | 30.71 | 0.40 | 0.00 | 3345 |
2025-05-09 | KYMR | 30.09 | 0.40 | 1.00 | 3345 |
2025-05-12 | KYMR | 32.17 | 0.40 | 0.33 | 3341 |
2025-05-13 | KYMR | 31.14 | 0.40 | 0.00 | 3341 |
2025-05-14 | KYMR | 29.72 | 0.40 | 0.00 | 3341 |
2025-05-15 | KYMR | 30.3 | 0.39 | 6.00 | 3323 |
2025-05-16 | KYMR | 30.27 | 0.39 | 999.99 | 3325 |
2025-05-19 | KYMR | 29.96 | 0.50 | 1.50 | 2688 |
2025-05-20 | KYMR | 31.43 | 0.50 | 1.00 | 2713 |
2025-05-21 | KYMR | 30.14 | 0.50 | 0.18 | 2715 |
2025-05-22 | KYMR | 30.16 | 0.50 | 0.13 | 2726 |
2025-05-23 | KYMR | 29.25 | 0.50 | 2.00 | 2734 |
2025-05-27 | KYMR | 28.14 | 0.50 | 3.00 | 2737 |
2025-05-28 | KYMR | 28.56 | 0.51 | 0.07 | 2753 |
2025-05-29 | KYMR | 30.27 | 0.50 | 1.00 | 2769 |
2025-05-30 | KYMR | 29.67 | 0.50 | 0.00 | 2773 |
2025-06-02 | KYMR | 43.12 | 0.50 | 1.35 | 2782 |
2025-06-03 | KYMR | 43.58 | 0.61 | 0.93 | 3249 |
2025-06-04 | KYMR | 44.28 | 0.64 | 4.00 | 3921 |
2025-06-05 | KYMR | 47.69 | 0.68 | 0.71 | 4044 |
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
21 items
«
‹
Current Page1 of 1
›
»
21 items
«
‹
of 1
›
»
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
---|---|---|---|---|---|
2025-05-07 | KYMR | 29.11 | -47.6 | -63.7 | -3.73 |
2025-05-08 | KYMR | 30.70 | -47.6 | -76.3 | -3.73 |
2025-05-09 | KYMR | 30.07 | -47.6 | -49.3 | -3.73 |
2025-05-12 | KYMR | 32.17 | -47.6 | -81.4 | -3.73 |
2025-05-13 | KYMR | 31.14 | -47.6 | -29.8 | -3.73 |
2025-05-14 | KYMR | 29.75 | -48.0 | -25.3 | -3.66 |
2025-05-15 | KYMR | 30.00 | -48.0 | -40.6 | -3.66 |
2025-05-16 | KYMR | 30.27 | -48.9 | -41.2 | -3.65 |
2025-05-19 | KYMR | 30.20 | -48.9 | -37.1 | -3.65 |
2025-05-20 | KYMR | 31.44 | -48.9 | -51.9 | -3.65 |
2025-05-21 | KYMR | 30.12 | -48.9 | -23.5 | -3.65 |
2025-05-22 | KYMR | 30.18 | -49.4 | -38.4 | -3.63 |
2025-05-23 | KYMR | 29.47 | -49.4 | -29.7 | -3.63 |
2025-05-27 | KYMR | 28.14 | -49.4 | -21.9 | -3.63 |
2025-05-28 | KYMR | 28.77 | -49.4 | -45.6 | -3.63 |
2025-05-29 | KYMR | 30.27 | -49.4 | -55.5 | -3.63 |
2025-05-30 | KYMR | 29.64 | -49.4 | -30.8 | -3.63 |
2025-06-02 | KYMR | 43.07 | -49.4 | -194.5 | -3.63 |
2025-06-03 | KYMR | 43.58 | -48.2 | -41.1 | -3.60 |
2025-06-04 | KYMR | 44.29 | -48.2 | -42.9 | -3.60 |
2025-06-05 | KYMR | 47.66 | -48.2 | -62.4 | -3.60 |
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
21 items
«
‹
Current Page1 of 1
›
»
21 items
«
‹
of 1
›
»
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
---|---|---|---|---|
2025-05-07 | KYMR | -0.19 | 4.24 | 13.79 |
2025-05-08 | KYMR | -0.19 | 4.24 | 13.79 |
2025-05-09 | KYMR | -0.19 | 4.24 | 13.79 |
2025-05-12 | KYMR | -0.19 | 4.59 | 13.45 |
2025-05-13 | KYMR | -0.19 | 4.59 | 13.45 |
2025-05-14 | KYMR | -0.19 | 4.59 | 13.41 |
2025-05-15 | KYMR | -0.19 | 4.59 | 13.45 |
2025-05-16 | KYMR | -0.19 | 4.59 | 13.45 |
2025-05-19 | KYMR | -0.18 | 5.69 | 13.51 |
2025-05-20 | KYMR | -0.18 | 5.69 | 13.51 |
2025-05-21 | KYMR | -0.18 | 5.69 | 13.51 |
2025-05-22 | KYMR | -0.18 | 5.69 | 13.51 |
2025-05-23 | KYMR | -0.21 | 5.69 | 13.51 |
2025-05-27 | KYMR | -0.21 | 2.37 | 13.50 |
2025-05-28 | KYMR | -0.21 | 2.37 | 13.14 |
2025-05-29 | KYMR | -0.21 | 2.37 | 13.14 |
2025-05-30 | KYMR | -0.21 | 2.37 | 13.14 |
2025-06-02 | KYMR | -0.21 | 2.73 | 13.14 |
2025-06-03 | KYMR | -0.19 | 2.73 | 13.14 |
2025-06-04 | KYMR | -0.63 | 2.73 | 13.14 |
2025-06-05 | KYMR | -0.63 | 2.73 | 13.14 |
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
21 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
-0.82
Avg. EPS Est. Current Quarter
-0.86
Avg. EPS Est. Next Quarter
-0.93
Insider Transactions
-0.63
Institutional Transactions
2.73
Beta
2.07
Average Sales Estimate Current Quarter
17
Average Sales Estimate Next Quarter
13
Fair Value
Quality Score
28
Growth Score
27
Sentiment Score
96
Actual DrawDown %
48.2
Max Drawdown 5-Year %
Target Price
62.32
P/E
Forward P/E
PEG
P/S
52.71
P/B
3.95
P/Free Cash Flow
EPS
-3.1
Average EPS Est. Cur. Y
-3.6
EPS Next Y. (Est.)
-4
Target Price Estimates Raised
4
Target Price Estimates Lowered
Profit Margin
-409.07
Relative Volume
1.55
Return on Equity vs Sector %
-54.6
Return on Equity vs Industry %
-36.8
EPS 1 7Days Diff
EPS 1 30Days Diff
0.14
EBIT Estimation
-62.4
Sector: Healthcare
Industry: Biotechnology
Employees: 208
Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase II clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa and atopic dermatitis. The company also develops STAT6, a type 2 inflammation in allergic and atopic diseases; and TYK2 to treat autoimmune and inflammatory diseases. Kymera Therapeutics, Inc. was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
stock quote shares KYMR – Kymera Therapeutics, Inc. Stock Price stock today
news today KYMR – Kymera Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch KYMR – Kymera Therapeutics, Inc. yahoo finance google finance
stock history KYMR – Kymera Therapeutics, Inc. invest stock market
stock prices KYMR premarket after hours
ticker KYMR fair value insiders trading